Stock listing

ANTX Stock Price, News, Filings & Events — An2 Therapeutics, Inc.

Selected listing: ANTX · NASDAQ · USD · US

This page tracks An2 Therapeutics, Inc.'s ANTX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ANTX:NASDAQ. ANTX:NASDAQ is the stock-level entry point for investors researching An2 Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. An2 Therapeutics, Inc. is a public company trading under the ticker ANTX in the American market. The company has a market capitalization of approximately $168.6 million. An2 Therapeutics focuses on developing innovative therapies to address unmet medical needs.

ANTX:NASDAQUSDUSUpdated September 11, 2026
An2 Therapeutics, Inc. logo
Ticker
ANTX:NASDAQ
Asset type
Stock
Market cap
$204.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

An2 Therapeutics, Inc. ANTX:NASDAQ stock context

This page tracks An2 Therapeutics, Inc.'s ANTX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ANTX:NASDAQ. ANTX:NASDAQ is the stock-level entry point for investors researching An2 Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. An2 Therapeutics, Inc. is a public company trading under the ticker ANTX in the American market. The company has a market capitalization of approximately $168.6 million. An2 Therapeutics focuses on developing innovative therapies to address unmet medical needs.

Latest news from An2 Therapeutics, Inc.

All An2 Therapeutics, Inc. news →

Research An2 Therapeutics, Inc.

Alternate listings